login
Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Hansen Medical showcases Magellan robotic system and NorthStar catheter at MEET congress in Italy


Wednesday, 07 Dec 2011 15:31
Magellan robotic system
Magellan robotic system


Hansen Medical showcased its Magellan robotic system at the Multidisciplinary European Endovascular Therapy (MEET) Congress, Rome, Italy (1–3 December 2011). 


The company also exhibited its NorthStar robotic catheter, designed to work with the Magellan robotic system. The NorthStar catheter is designed to simplify and enhance catheter navigation and therapeutic intervention in the peripheral vasculature. The Magellan robotic system and NorthStar robotic catheter are CE-marked and available for sale in Europe. They are 510(k) pending and not available for sale in the United States.


“We are excited to showcase our Magellan robotic system and NorthStar robotic catheter at this foremost exhibition on endovascular therapy, and this is an important event in the initial commercial launch of our new system platform,” said Bruce Barclay, president and CEO of Hansen Medical. “Based on the initial clinical and pre-clinical work and feedback from a number of leading clinicians worldwide, these products have the potential to optimise the way physicians navigate the vasculature. The CE marked system and catheter give physicians maximum flexibility and control through independent distal tip control of a catheter and a sheath as well as through robotic manipulation of a standard guidewire from a centralised, remote workstation. Moreover, this proprietary technology has the ability to provide physicians important clinical benefits by allowing precise and predictable catheter navigation of peripheral vessels.”


The Magellan robotic system and NorthStar robotic catheter are intended to be used to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices.


Last year, the company announced the completion of its first-in-man study in Europe during which 20 endovascular procedures were performed with an earlier version of the Magellan robotic system, demonstrating its potential to allow physicians to treat peripheral vascular disease, while lessening radiation exposure.




Add New Comment

Most popular


Abbott to acquire St Jude Medical
Tuesday, 03 May 2016
Abbott is set to acquire St Jude Medical, expanding its portfolio to cover cardiovascular markets such as atrial fibrillation, structural heart and heart failure as well as neuromodulation. The ... Abbott to acquire St Jude Medical

FDA clears CorPath robotic system for use in peripheral vascular intervention
Tuesday, 29 Mar 2016
This 510(k) clearance for peripheral intervention was based on results of a clinical trial known as the RAPID (Robotic-assisted peripheral intervention for peripheral artery disease) study conducted ... FDA clears CorPath robotic system for use in peripheral vascular intervention

Monday, 11 Apr 2016
A study conducted at St Thomas’ Hospital, London, UK, indicates that the VeinCLEAR catheter (RF Medical) produces good results when used in radiofrequency ablation in the treatment of lower extremity ... VeinCLEAR catheter shows short-term success of venous closures during radiofrequency ablation

Features


Image-guided biopsy in the era of personalised cancer care
Thursday, 12 May 2016
While most radiologists probably do not view a biopsy as being the most exciting or technically challenging procedure within our repertoire, it may be time to give the image-guided biopsy a second ... Image-guided biopsy in the era of personalised cancer care

A research track record helps physicians assess new technology
Tuesday, 12 Apr 2016
Scott Trerotola, Stanley Baum Professor and chief, Vascular and Interventional Radiology, University of Pennsylvania Medical Center, Philadelphia, USA, delivered the Dr Charles T Dotter Lecture at ... A research track record helps physicians assess new technology

Profiles


Gabriel Bartal
Thursday, 26 Nov 2015
“In the early days, I used to have to cut a 7F plastic tube, make side holes, send it off for ... Gabriel Bartal

Lindsay Machan
Thursday, 28 May 2015
“Focusing on maximising rewards has sidelined more ideas than it has helped individual inventors. S... Lindsay Machan

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions